INTRODUCTION
============

*Streptococcus agalactiae* is the principal cause of bacterial sepsis, neonatal meningitis and endocarditis in parturient women. It is also a cause of pneumonia particularly in the immunocompromised elderly ([@B1]). *S. agalactiae* commonly colonizes the gastrointestinal and urogenital tracts of humans ([@B2]) and the proteins enabling the bacteria for colonization, invasion and evasion are poorly defined ([@B3]).

The interaction between *S. agalactiae* and the epithelial cells is mediated by a heterogeneous system known as extracellular matrix (ECM). This system includes the components both fibronectin and fibrinogen ([@B2]). The fibronectin functions as a binding site for *S. agalactiae* through an insoluble phase ([@B4], [@B5]). A sequence of arginine, glycine and aspartic acid (RGD) in fibronectin is also involved in binding to proteins ([@B6]). Furthermore, C5a peptidase has a high affinity to the RGD sequence of the fibronectin and plays a significant role in adhesion and invasion ([@B4]). However, the fibrinogen in *S. agalactiae* performs key role in attachment ([@B7]) and FbsA and FbsB are recognized fibrinogen-binding proteins ([@B2]). The FbsA binds to cell wall covalently because of LPXTG motif while the FbsB seems to be secreted due to lack of such motif ([@B8]). Both proteins promote the entry of the *S. agalactiae* into the epithelial cells ([@B9]).

*S. agalactiae* also possess a dynamic structure called peptidoglycan. This str ucture like other Gram-positive bacterial cell wall contains peptidoglycan hydrolases. These enzymes play an important role in remodeling, turnover, division and separation of the cell wall ([@B10]). In critical situations, some of the peptidoglycan hydrolases(autolysin) facilitate self-disintegration(autolysis) of the peptidoglycan ([@B11], [@B12]). *S. agalactiae* and *Staphylococcus aureus* are both Gram positive cocci from different genus. While there is no clear evidence about the details of autolysin in *S. agalactiae, S. aureus* (Atl) contains two major domains of autolysin: amidase and glucosaminidase ([@B11]). The glucosaminidase domain ionically binds to fibronectin ([@B13]). Another autolysin of *S. aureus* (Aaa) is bifunctional, and it also mediates adherence to immobilized fibrinogen and fibronectin ([@B14]). Similar roles were found in other *Streptococcus* species such as *Streptococcus pneumoniae* ([@B15]). The *S. agalactiae* contains proteins which are not fully understood of their roles, like Gbs1805.

In this study, AFb, which is a novel protein encoded by *gbs1805* gene in *S. agalactiae* was cloned, over expressed and purified. *In silico* analysis of AFb indicates amidase activity and great homology to other *Streptococci* genus. Moreover, the binding ability of AFb to plasma proteins was examined.

MATERIALS AND METHODS
=====================

This experimental study was performed on functional analysis of *gbs1805* gene of *S. agalactiae.*

Bacterial strains, plasmids and culture conditions.
---------------------------------------------------

The strains and plasmids used in this study are presented in [Table 1](#T1){ref-type="table"}. The *S. agalactiae* isolate were grown on blood agar enrichedby 5% sheep blood. Also, *Escherichia coli* strains were cultured overnight on Luria Bertani (LB) (Merck, Germany) broth at 37 °C. Ampicillin (0.1mg/ml) was added to the cultures when required.

###### 

Bacterial strains and plasmids

  Strains and plasmids         Genotype or Description                                     Source
  ---------------------------- ----------------------------------------------------------- ---------------
  *E. coli* strains            dlacZ Delta M15 Delta(lacZYA-argF)                          
  DH5α                         U169 recA1 endA1 hsdR17(rK-mK+) supE44 thi-1 gyrA96 relA1   Novagen, UK
  BL21                         F\_ *ompT gal (dcm) (lon) hsdS*B (rB\_ mB\_)                
  *Streptococcus agalactiae*   Clinical isolate                                            This Study
  *p*ET21a                     His6-tagged vector Amp^r^                                   Stratagen, UK

PCR amplification of the *gbs1805* gene.
----------------------------------------

Chromosomal DNA of *S. agalactiae* was extracted using DNA Extraction Kit (Promega, USA) based on the manufacturer's instructions. The upstream (GCGCGCCATATGATACATATAACTATGCAGTAGATGTA) and the downstream (GCGCGCCTCGAGATTCGGATAAATGTAGCTAACTAC) primers (20pmol/μl) with the underlined restriction sites were used to amplify the *gbs1805* gene at: 95 °C for 5 min, 95 °C for 1 min, 59 °C for 45 seconds (30 cycles), 72 °C for 45 seconds and 72 °C for 10 seconds.

Cloning and Overexpression.
---------------------------

The amplified gene and *p*ET21a were double digested by *Nde*I and *Xho*I enzymes (Takara, Japan) and ligated using T4 ligase (Takara, Japan). Then, the recombinant vector was transformed to *Escherichia coli* DH5α. Then positive clones were chosen fromthe ampicillin-supplemented LB agar plates and were confirmed by colony PCR and sequencing of plasmid. The positive clones then were transformed to the expression host, *E. coli* BL21. The overexpression was optimized at 37 °C, 1mM/ml IPTG (Fermentas, USA) for 4 hours oncethe culture has reached OD~600~ of 0.6.

Protein purification.
---------------------

The recombinant insoluble protein was purified by Qiagen purification kit (Qiagen, Netherland) based on the manufacturer's instructions. The purification process included 4 steps: cell lysis, binding, washing and elution. The procedure was performed using urea buffers under PH reducing conditions.

SDS-PAGE, Western blotting.
---------------------------

The purified protein was indicated by SDS-PAGE. 12.5% SDS-PAGE gel was applied to analyze the purified recombinant protein by Coomassie brilliant blue staining. Western blot was used to confirm the His-tagged recombinant protein. Briefly, the recombinant protein was size-separated on SDS-PAGE gel. Then it was electroblotted to nitrocellulose membrane. The membrane was blocked overnight (4 °C) with 3% skimmed milk in PBS. Subsequently, it was washed three times in a washing buffer (Tween 20 and PBS) and incubated in His-tag antibody (Sigma, USA) diluted in 1:1000 in PBS for 1h at room temperature. Afterwards, the membrane was washed three times and DAB substrate (3, 3′-Diaminobenzidine) (Sigma, USA) was added to detect the recombinant protein.

Western blotting was used to assess binding to biotinylated plasma proteins (fibrinogen and fibronectin). Ant II was used as a positive control. The recombinant protein was electroblotted on nitrocellulose membrane as previously mentioned. After blocking and washing the membrane, it was incubated in plasma protein (fibrinogen and fibronectin) diluted in 1:1000 for 3h at room temperature. Then the membrane was washed as before and incubated in Streptavidin (Roche, Germany) diluted washing buffer in 1:30000 at room temperature for 3h. Subsequently, the membrane was washed and incubated in alkaline phosphatase buffer for 5 min. Then the membrane was immersedin NBT/BCIP (Roche, Germany) solution and kept in dark condition until the protein band appears.

RESULTS
=======

The *gbs1805* gene was amplified by PCR ([Fig. 1](#F1){ref-type="fig"}) and cloned into *p*ET21a in *E. coli* DH5α as cloning host. Then, the constructed plasmid was transformed into BL21 and expressed as a hexahistidyl-tagged protein. The recombinant protein was successfully purified using Ni-NTA (Qiagen, Netherland), as predicted by bioinformatics analysis in JCVI. A full sized 18 KDa mature protein was indicated by the SDS- PAGE ([Fig. 2](#F2){ref-type="fig"}). Then, the purified His6-tagged recombinant protein was confirmed by anti his-tag western blot experiment ([Fig. 3](#F3){ref-type="fig"}). The binding ability of the bacterium to the fibrinogen and fibronectin are shown [Fig. 4](#F4){ref-type="fig"}.

![Amplification of *gbs1805* gene (432bp). (M) Marker 100bp (GeneOn, USA), ([@B1]) Positive Control *Streptococcus agalactiae* NEM316, (2--4) Clinical isolates.](IJM-8-73-g001){#F1}

![Confirmation of protein purification by SDS PAGE. (M): Unstained protein marker (Fermentas, USA), Lane1: Purified Recombinant protein (18 KDa).](IJM-8-73-g002){#F2}

![Anti His6-tagged recombinant protein. Lane1: Prestained Marker (Sinaclon, Iran), Lane2: Recombinant protein (18 KDa).](IJM-8-73-g003){#F3}

![(A) Fibrinogen protein binding assay. Lane 1: Prestained Marker (Sinaclon, Iran), Lane 2: Positive control (Ant II), Lane 3: Recombinant protein (18 KDa). (B) Fibronectin protein binding assay. Lane 1: Prestained Marker (Sinaclon, Iran), Lane 2: Positive control (Ant II), Lane 3: Recombinant protein (18 KDa).](IJM-8-73-g004){#F4}

DISCUSSION
==========

Attachment to specific receptors is the initial step in the pathogenesis of Gram-positive bacteria ([@B16]). The most common receptors mediating adherence to epithelial cells including fibrinogen and fibronectin are parts of the extra cellular matrix (ECM) ([@B2], [@B17]) and fibrinogen and fibronectin are known to be the major components of the ECM in a number of Gram-positive bacteria ([@B18], [@B19]). In this study, AFb (Autolysin, Fibrinogen/Fibronectin binding), is identified to be a novel protein of Group B Streptococcus capable of bindingto fibrinogen and fibronectin. *S. agalactiae* interacts with fibrinogen via a variety of proteins including FbsA, FbsB, FbsC, Srr1 and Srr2 ([@B2], [@B8], [@B20], [@B21]). Fibrinogen is expressed on epithelial and endothelial cell surfaces and interferes complement activation ([@B22]), phagocytosis and polymorphonuclear activation ([@B23]). Since FbsA protects *S. agalactiae* against opsonophagocytosis ([@B9]), deletion of *fbsA* leads to reduced proliferation of the bacterium in blood ([@B7]). The interaction of Srr1 and fibrinogen contribute to pathogenesis and plays key role in attachment to brain microvascular endothelial cells ([@B24]). The binding ability to epithelial and endothelial cells, biofilm formation and invasion decreases significantly in *fbsC*-negative mutants ([@B20]). Furthermore, FbsA and FbsB also participate in evasion of host defense ([@B23]).

Fibronectin, another component of ECM, produce-sA549 on cell surfaces in the respiratory tract and on vaginal and cervical cells ([@B6], [@B25]). The well-defined fibronectin binding protein of Group B Streptococcus encoded by *scpB* gene, known asC5a peptidase, adheres to epithelial cells and involved in evasion ([@B4]). *S. agalactiae* binds to immobilized fibronectin ([@B5]). However, the *scpB* defective mutant *S. agalactiae's* attachment to fibronectin significantly decreaseswhen compared to the wild strain ([@B6]). This suggeststhe involvement ofmultiple factors in the fibronectin binding process. In addition to the binding activity of AFb, it seems to be a peptidoglycan hydrolase. The possible role of the *AFb* in the attachment process and its substantial pathogenicity is not well recognized due to the lack of afb-defective mutant *S. agalactiae.*

Commonly, peptidoglycan hydrolases deal with cell separation, turn over, remodeling, and degradation of cell wall. Evidence shows that peptidoglycan hydrolases, autolysins, are involved in the pathogenesis and virulence of Gram-positive bacteria by mediating bacterial adherence ([@B26], [@B27]). To date numerous autolysin/adhesion proteins including Aaa, Atl, Aas, Aae, LytM, AmiC, etc which confirmed binding to ECM are described undergram-positive bacteria ([@B11], [@B13]--[@B15], [@B28]). In vivo studies demonstrated that autolysin-defective mutants to be less virulent than wild type strains of *Listeria monocytogenes, S. aureus, S. pneumonia,* and *S. epidermidis* ([@B29]--[@B31]). *In silico* studies of AFb demonstrated high homology to amidase, and zymography confirmed the activity in vitro ([Fig 5](#F5){ref-type="fig"}). Therefore, AFb can be a bifunctional protein, based on its binding affinity to two plasma proteins and amidase like activity. Using patients' sera, we did not get any evidence showing antigenic activity.

![(A). Sequence of the *gbs1805* gene. Red: Nucleic acid sequence of signal peptide. (B). Amino acid sequence of the AFb (the recombinant protein). (C). Multiple alignment of AFb to other protein of *Streptococcus agalactiae*](IJM-8-73-g005){#F5}

CONCLUSION
==========

The AFb is a novel protein encoded by *gbs1805* in *S. agalactiae* and is capable to bind with the plasma proteins - fibrinogen and fibronectin. The role of the protein in adhesion and colonization of the bacterium is unknown and needs further investigation.
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